COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING

Scope & Guideline

Exploring the Future of Organic Chemistry Innovation

Introduction

Delve into the academic richness of COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1386-2073
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 1998 to 2024
AbbreviationCOMB CHEM HIGH T SCR / Comb. Chem. High Throughput Screen
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

The journal 'Combinatorial Chemistry & High Throughput Screening' focuses on the advancement of combinatorial chemistry and high-throughput screening methodologies in drug discovery and related fields. Its aims include fostering the development of novel therapeutic agents through innovative chemical and biological techniques.
  1. Combinatorial Chemistry Techniques:
    The journal emphasizes the use of combinatorial chemistry to synthesize a diverse range of compounds, facilitating the discovery of new drugs and bioactive molecules.
  2. High-Throughput Screening:
    Focus on high-throughput screening methodologies to rapidly assess the biological activity of large compound libraries, enabling efficient identification of lead compounds.
  3. Network Pharmacology:
    Integration of network pharmacology approaches to elucidate the mechanisms of action of compounds, including their interactions within biological networks.
  4. Experimental Validation:
    Encouragement of experimental validation of findings from combinatorial and high-throughput screening studies, ensuring that theoretical predictions are supported by empirical data.
  5. Natural Product Research:
    Investigation of natural products and their derivatives as potential therapeutic agents, leveraging traditional knowledge and modern analytical techniques.
The journal has seen a rise in certain themes reflecting the evolving landscape of pharmaceutical research. These emerging scopes indicate where the focus is shifting within the field.
  1. Integrative Multi-Omics Approaches:
    There is a growing trend towards using integrative multi-omics approaches, combining genomics, proteomics, and metabolomics to provide comprehensive insights into drug mechanisms and biological effects.
  2. Artificial Intelligence in Drug Discovery:
    The incorporation of artificial intelligence and machine learning techniques for predicting drug interactions, optimizing compounds, and analyzing biological data is rapidly gaining traction.
  3. Bioinformatics and Computational Modeling:
    An increase in studies utilizing bioinformatics tools and computational modeling to predict drug activity and interactions, reflecting a shift towards data-driven research.
  4. Ethnopharmacology and Natural Products:
    Revitalized interest in ethnopharmacology and the exploration of natural products as therapeutic agents, focusing on their bioactive compounds and mechanisms of action.
  5. Targeted Therapies and Personalized Medicine:
    Growing focus on targeted therapies and personalized medicine approaches, highlighting the importance of tailored treatments based on individual patient profiles.

Declining or Waning

While certain areas remain strong, there are emerging trends that suggest a decline in others within the journal's scope. The following themes show waning interest or publication frequency.
  1. Traditional Medicinal Practices:
    Research focused on traditional medicinal practices and their integration with modern pharmacological approaches appears to be declining, as the journal shifts towards more contemporary methodologies.
  2. Single-target Drug Discovery:
    There is a noticeable decrease in studies solely focusing on single-target drug discovery, as the field increasingly recognizes the complexity of biological systems and the need for multi-target approaches.
  3. Basic Pharmacology Studies:
    Basic pharmacology studies without a clear connection to combinatorial chemistry or high-throughput screening seem to be less prevalent, reflecting a shift towards more applied research.
  4. In vitro Studies without Integration:
    Research that does not integrate in vitro findings with computational or network pharmacology approaches is becoming less common, as the field moves towards more holistic methodologies.

Similar Journals

Chemical Biology & Drug Design

Fostering breakthroughs in molecular medicine and drug design.
Publisher: WILEYISSN: 1747-0277Frequency: 12 issues/year

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

Journal of Natural Medicines

Exploring the Frontiers of Natural Therapeutics
Publisher: SPRINGER JAPAN KKISSN: 1340-3443Frequency: 4 issues/year

Journal of Natural Medicines, published by SPRINGER JAPAN KK, is a leading academic journal that plays a pivotal role in the advancement of research in the fields of Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, and Pharmaceutical Science. Established in 1994 and set to continue until 2024, this journal serves as a vital conduit for the dissemination of groundbreaking research and innovative ideas that bridge traditional medicinal knowledge and modern scientific inquiry. With its impressive ranking in Scopus—ranking #12 out of 105 in Complementary and Alternative Medicine and holding a Q1 category quartile for 2023—it stands as a reputable source for high-quality, peer-reviewed articles. The journal's commitment to excellence is further underscored by its inclusion in the Springer network, providing researchers, professionals, and students with valuable insights and the latest developments in natural medicines. Although this journal operates under a subscription model, its profound impact on these interdisciplinary fields makes it an essential resource for anyone engaged in the study or practice of natural medicinal therapies.

Natural Products Journal

Exploring the Essence of Nature in Health and Healing
Publisher: BENTHAM SCIENCE PUBLISSN: 2210-3155Frequency: 4 issues/year

Natural Products Journal, a leading publication by Bentham Science Publishers, primarily focuses on the rapidly evolving field of Natural Products and their applications in Complementary and Alternative Medicine as well as Drug Discovery. With an ISSN of 2210-3155 and an E-ISSN of 2210-3163, this journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the critical role of natural compounds in health and medicine. Since its inception in 2011, it has consolidated its reputation, achieving a Q3 ranking in Complementary and Alternative Medicine and a Q4 ranking in Drug Discovery as of 2023, illustrating its growing influence within the academic community. Although it currently does not operate as an Open Access journal, it remains a vital resource for cutting-edge research and developments in natural products, offering insightful contributions that pave the way for innovative therapeutic strategies. Located in the Netherlands, the journal is pivotal for those looking to stay at the forefront of research in natural substances and their multifaceted applications.

NATURAL PRODUCT RESEARCH

Pioneering Discoveries in Plant and Organic Chemistry
Publisher: TAYLOR & FRANCIS LTDISSN: 1478-6419Frequency: 24 issues/year

NATURAL PRODUCT RESEARCH is a distinguished journal published by Taylor & Francis Ltd, dedicated to advancing the field of natural product science through the dissemination of high-quality research. Established in 2003, this journal serves as a pivotal platform for scholars in Analytical Chemistry, Biochemistry, Organic Chemistry, and Plant Science, boasting an impressive categorization including Q2 in Plant Science and Q3 in the other disciplines for 2023. With a current Scopus ranking that highlights its significance within various scientific communities, NATURAL PRODUCT RESEARCH reflects the complexities and innovations associated with natural compounds and their applications. Researchers, professionals, and students will find valuable insights and breakthroughs that contribute to the understanding of bioactive compounds and their roles in health and environmental sustainability. Access options are available, ensuring that the latest findings are accessible to a global audience. As this journal continues to publish until 2024, it remains an essential resource for those at the forefront of natural product research.

Advances in Pharmacological and Pharmaceutical Sciences

Pioneering Insights in Toxicology and Drug Development.
Publisher: HINDAWI LTDISSN: 2633-4682Frequency: 1 issue/year

Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.

PHARMACEUTICAL CHEMISTRY JOURNAL

Advancing Drug Discovery Through Scholarly Excellence.
Publisher: SPRINGERISSN: 0091-150XFrequency: 12 issues/year

Pharmaceutical Chemistry Journal is a pivotal publication in the field of pharmaceutical sciences, renowned for its in-depth articles and research findings. Published by Springer in the United States, this journal provides a crucial platform for researchers, students, and professionals dedicated to advancing drug discovery and pharmacology. With an ISSN of 0091-150X and an E-ISSN of 1573-9031, this journal has consistently aimed to promote scholarly communication and innovation within its scope since its inception in 1967. Despite its current Category Quartiles ranking of Q4 in both Drug Discovery and Pharmacology, the journal remains a valuable resource for disseminating new ideas and findings that contribute to the scientific community. Researchers benefit from the journal's commitment to high-quality peer-reviewed content, even in an environment where open access options are currently not available. As the field evolves, the Pharmaceutical Chemistry Journal continues to play an important role in shaping future advancements in drug development and safety.

ChemMedChem

Innovating drug discovery through interdisciplinary collaboration.
Publisher: WILEY-V C H VERLAG GMBHISSN: 1860-7179Frequency: 24 issues/year

ChemMedChem is a leading international journal published by WILEY-V C H VERLAG GMBH in the United Kingdom, specializing in the interdisciplinary fields of medicinal chemistry and drug discovery. With a commendable impact factor that places it in the Q1 quartile for Organic Chemistry and among the Q2 ranks in several other key categories including Biochemistry, Molecular Medicine, and Pharmacology, ChemMedChem serves as a vital platform for the dissemination of innovative research and transformative insights in the development of pharmaceutical agents. Since its inception in 2006, this journal has been at the forefront of advancing knowledge that bridges the gap between fundamental research and practical applications in medicine, making it an essential resource for researchers, professionals, and students alike. Although it currently does not offer Open Access options, the journal ensures high-quality peer-reviewed content that engages its audience and fosters collaborative scientific discourse.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Unraveling the complexities of medicinal chemistry.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-894XFrequency: 24 issues/year

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, published by PERGAMON-ELSEVIER SCIENCE LTD, is a leading journal in the fields of biochemistry, drug discovery, and medicinal chemistry, designed to disseminate significant advances in these disciplines. Established in 1991, the journal spans various important categories, including Organic Chemistry and Pharmaceutical Science, with its 2023 Scimago Journal Rank placing it at Q2 in Organic Chemistry and Q3 in several other relevant fields. Though not an open-access publication, it provides invaluable insights into contemporary research and innovative methodologies, appealing to researchers, professionals, and students alike. The journal's commitment to quality and relevance makes it a vital resource for those aiming to stay at the forefront of bioorganic and medicinal chemistry developments. For more information, please visit the journal's website as it remains a critical platform for scholarly exchange, particularly for those engaged in interdisciplinary research.

BIOORGANIC & MEDICINAL CHEMISTRY

Elevating Knowledge in Bioorganic & Medicinal Chemistry
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0968-0896Frequency: 24 issues/year

BIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.

LETTERS IN ORGANIC CHEMISTRY

Advancing the Frontiers of Organic Chemistry
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1786Frequency: 12 issues/year

LETTERS IN ORGANIC CHEMISTRY is a distinguished journal published by Bentham Science Publishers Ltd, focusing on the rapidly evolving field of organic chemistry. Established in 2005, the journal commits itself to disseminating vital research findings, reviews, and innovative methodologies that contribute to the understanding and advancement of organic chemistry and biochemistry. With an ISSN of 1570-1786 and an E-ISSN of 1875-6255, this journal enhances accessibility and visibility for authors and readers alike, albeit not adopting an open-access model. Positioned within Q4 quartile rankings for both Biochemistry and Organic Chemistry, it serves a niche audience keen on exploring emerging trends and breakthroughs in these disciplines. Its Scopus rankings further reflect its role in the global academic landscape, albeit at the beginning stages of its impact journey. Based in the United Arab Emirates, LETTERS IN ORGANIC CHEMISTRY is dedicated to fostering dialogue among researchers and practitioners, paving the way for future innovations in organic and biochemical sciences.